PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY FIBROSIS.

NCT06917196 · clinicaltrials.gov ↗

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Arterial Hypertension (PAH)
Lung Fibrosis Interstitial

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia